Ahead of the Quaid Vaccine: Children Under 12

“I don’t think it will expand from 12 to 15,” said Dr. Bob Frank, director of the Cincinnati Children’s Hospital Vaccine Research Center.

However, parents are already claiming to hear more about the approval or permission of children under 12. The study is ongoing.

Frank told CNN that it seems that children can get a much smaller dose of the vaccine than adults and still have the same immune response.

That’s good news, Frank said, because it means the supply of vaccines could be further increased.

“We took a step back after the teens did, and we looked at food, because we thought we might be able to use less food and get the same immune response,” said Frank. Are. “

“It seems that children between the ages of 5 and 12 have a strong immune response to 10 micrograms of the vaccine antigen,” Frank said.

“So one-third of the dose we were giving to adults, or one-third of the dose used at 12 years of age and older, was as immune. We got as good an immune response as a 30-microgram dose and less There were effects, “he said.

“So because of that, we’re looking at 10 micrograms for a 5-12 year old diet, and then in young children, under 5 years old, even going up to 3 micrograms more.”

Frank said it may be confusing, but it simply means that children’s immune systems are stronger. “It really does prove that the children’s immune response is good. They are very strong,” he said.

“A lot of people are asking us: ‘Does that mean you’re giving us less vaccines?’ I said, well, we’re giving you less antigen, but their immune response is so good that they’re giving the same immune response – so there’s no need for more vaccines, “Frank added.

“We’re giving enough vaccines to get the same immune response we’re seeing in people over the age of 25 who are getting 30 micrograms.”

These routine shots are already required in schools, as most states ban the requirement for the Kovid 19 vaccine.

Not much better, Frank said – the immune response is maximal and over-feeding does not increase it.

“We managed to reduce it by a third, and still got the same immune response,” he said.

As adults, side effects are usually mild and do not last long, Frank said.

“The side effects we’re seeing in children are really the same as we’re seeing in adults,” Frank said. About 10% of children suffer from arm, fatigue, headache and fever, he said.

Dr Anthony Fookie, director of the National Institute of Allergy and Infectious Diseases, said he was confident the trials would work well in young children.

“I don’t think there’s any question that it’ll be useful to kids at this young age. I have no doubt,” Fookie told CNN’s Anderson Cooper Monday evening.

Dr. Amanda Drapak, a pediatrician in Florence, Kentucky, admitted her four children to trials of different ages at Cincinnati Children’s.

“I talked to my kids about it,” she said in a video released from the hospital. “

“We stop traveling. We miss the holidays. We miss the concert,” Dropak said.

Millions of teenagers will return to school without vaccinations.

“I’m really looking forward to hanging out with friends,” said Ben, Dropak’s son.

“It’s important to get vaccinated so you can stop the spread of the corona virus and the virus will no longer harm people,” said Ben’s younger brother, Eli, 10.

Frank’s team is starting vaccine trials and is now testing Moderna’s Covid 19 vaccine in children under 12. The hospital has to admit 75 children.

Like all coronavirus vaccine trials, investigators such as Frank are stepping up bureaucratic measures to collect vaccine data to speed up the process.

“What usually happens is that you get the result of Phase 1 (trial) and then you show it back to the company and say, ‘Well, is it so good that we have Phase 2?’ I’m going, and then you have to think about it. And then you did the same thing with Phase 2 to Phase 3.

The 12-year-old is happy to be tested on the Covid 19 vaccine.

Often a study lasts four or five years, and the researchers collect all the data at the end of this study period and submit it to the FDA. “So you can imagine getting four or five years of data at a time,” he said.

“What happened here was that the FDA was being given information packets in real time. As the companies get the information, it is being submitted to the FDA for their review so that when they have an emergency. Arrive at a location to see usage. Permission, the FDA was already very familiar with the product and did not need to start from Ground Zero. “

Modern is also considering a low-dose diet for young children, Frank said.

Pfizer says it will apply to the FDA for permission to use its vaccine in children aged 5-11 by the end of September, when it sends all the data.

Moderina, whose vaccine is authorized for people 18 and older, has applied to the EUA for 12-17 children. It expects to have data on young children by the end of this year.

Johnson & Johnson is in “active discussions with regulatory authorities regarding our development plans and pilot designs” for teens and children and expects trials to begin in the fall.


Leave a Reply

Your email address will not be published.